AlphaYouSC
Congress trade
Sen. Susan Collins (R-ME) sold $1K-$15K of Celgene Corporation (NASDAQ) (CELG) stock
Susan Collins, U.S. Senator (R-ME), disclosed a sale of Celgene Corporation (NASDAQ) (CELG) stock worth $1K-$15K in a STOCK Act filing on Feb 5, 2014.
The trade happened on Jan 30, 2014, 6 days before it was made public.
- Traded
- Jan 30, 2014
- Disclosed
- Feb 5, 2014
- Filing delay
- 6 days
- Source
- STOCK Act disclosure
Other trades in this disclosure (5)
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.